Haleon to take full ownership of Chinese joint venture.
Haleon announced on Tuesday that it has agreed to acquire the remaining 12% stake in its Chinese over-the-counter joint venture, Tianjin TSKF Pharmaceutical, for CNY 1.623bn (around £200m), bringing its total ownership to 100%.
Haleon
15 April 2025 11:54:02
Source: Sharecast
The FTSE 100 consumer products giant said the deal followed its acquisition of a 33% stake in TSKF in December, and would result in the business becoming a wholly-owned subsidiary.
It said the transaction would be funded through a mix of existing cash and new renminbi-denominated debt from third-party sources.
Completion was expected within the next three months, subject to customary conditions including shareholder approval from Haleon’s partner Tianjin Pharmaceutical Da Ren Tang Group, and necessary regulatory clearances.
At 1135 BST, shares in Haleon were up 0.04% at 379.14p.
Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.
